The current scenario isn't working IMO if the majority of the cost comes from the approval process.
Drugs for me er fairly cheap as I come from Denmark.
With regards to proof. The article we are debating here is proof that since the production of a drug is extremely cheap the development of it is extremely expensive.
The current scenario isn't working IMO if the majority of the cost comes from the approval process.
Drugs for me er fairly cheap as I come from Denmark.
With regards to proof. The article we are debating here is proof that since the production of a drug is extremely cheap the development of it is extremely expensive.
Surely that cost can be cut.